Hollsteen
← Cadence

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 2016: $31.0M · 10-Q 0000813672-16-000045 filed Apr 25, 2016D&A · Q2 2016: $32.0M · derived · 10-Q 0000813672-17-000017 filed Jul 24, 2017D&A · Q3 2016: $27.0M · derived · 10-Q 0000813672-17-000023 filed Oct 26, 2017D&A · Q4 2016: $30.0M · derived · 10-K 0000813672-18-000008 filed Feb 20, 2018D&A · Q1 2017: $29.0M · 10-Q 0000813672-17-000011 filed Apr 25, 2017D&A · Q2 2017: $29.0M · derived · 10-Q 0000813672-18-000020 filed Jul 23, 2018D&A · Q3 2017: $28.0M · derived · 10-Q 0000813672-18-000025 filed Oct 22, 2018D&A · Q4 2017: $29.0M · derived · 10-K 0000813672-19-000008 filed Feb 27, 2019D&A · Q1 2018: $29.0M · 10-Q 0000813672-18-000014 filed Apr 25, 2018D&A · Q2 2018: $30.0M · derived · 10-Q 0000813672-19-000022 filed Jul 22, 2019D&A · Q3 2018: $30.0M · derived · 10-Q 0000813672-19-000027 filed Oct 21, 2019D&A · Q4 2018: $30.0M · derived · 10-K 0000813672-20-000007 filed Feb 24, 2020D&A · Q1 2019: $30.0M · 10-Q 0000813672-19-000014 filed Apr 22, 2019D&A · Q2 2019: $31.0M · derived · 10-Q 0000813672-20-000020 filed Jul 20, 2020D&A · Q3 2019: $30.0M · derived · 10-Q 0000813672-20-000027 filed Oct 19, 2020D&A · Q4 2019: $31.0M · derived · 10-K/A 0000813672-21-000021 filed May 14, 2021D&A · Q1 2020: $33.0M · 10-Q 0000813672-20-000013 filed Apr 20, 2020D&A · Q2 2020: $37.0M · derived · 10-Q 0000813672-21-000028 filed Jul 26, 2021D&A · Q3 2020: $37.0M · derived · 10-Q 0000813672-21-000037 filed Oct 25, 2021D&A · Q4 2020: $39.0M · derived · 10-K 0000813672-22-000012 filed Feb 22, 2022D&A · Q1 2021: $36.0M · 10-Q 0000813672-21-000016 filed Apr 26, 2021D&A · Q2 2021: $36.0M · derived · 10-Q 0000813672-22-000037 filed Jul 25, 2022D&A · Q3 2021: $35.0M · derived · 10-Q 0000813672-22-000054 filed Oct 24, 2022D&A · Q4 2021: $35.0M · derived · 10-K 0000813672-23-000011 filed Feb 13, 2023D&A · Q1 2022: $35.0M · 10-Q 0000813672-22-000022 filed Apr 25, 2022D&A · Q2 2022: $33.0M · derived · 10-Q 0000813672-23-000041 filed Jul 24, 2023D&A · Q3 2022: $30.0M · derived · 10-Q 0000813672-23-000068 filed Oct 23, 2023D&A · Q4 2022: $34.0M · derived · 10-K 0000813672-24-000034 filed Feb 14, 2024D&A · Q1 2023: $34.0M · 10-Q 0000813672-23-000025 filed Apr 24, 2023D&A · Q2 2023: $36.0M · derived · 10-Q 0000813672-24-000155 filed Jul 24, 2024D&A · Q3 2023: $36.0M · derived · 10-Q 0000813672-24-000192 filed Oct 30, 2024D&A · Q4 2023: $39.0M · derived · 10-K 0000813672-25-000024 filed Feb 21, 2025D&A · Q1 2024: $40.0M · 10-Q 0000813672-24-000092 filed Apr 24, 2024D&A · Q2 2024: $48.0M · derived · 10-Q 0000813672-25-000113 filed Jul 30, 2025D&A · Q3 2024: $55.0M · derived · 10-Q 0000813672-25-000148 filed Oct 29, 2025D&A · Q4 2024: $55.0M · derived · 10-K 0000813672-26-000016 filed Feb 19, 2026D&A · Q1 2025: $53.0M · 10-Q 0000813672-25-000051 filed Apr 30, 2025D&A · Q2 2025: $54.0M · derived · 10-Q 0000813672-25-000113 filed Jul 30, 2025D&A · Q3 2025: $57.0M · derived · 10-Q 0000813672-25-000148 filed Oct 29, 2025D&A · Q4 2025: $65.0M · derived · 10-K 0000813672-26-000016 filed Feb 19, 2026D&A · Q1 2026: $85.0M · 10-Q 0000813672-26-000047 filed May 1, 202684.631.2Q1 2016Q1 2026Q1 2021
$MD&A · Q2 2024: $48.0M · derived · 10-Q 0000813672-25-000113 filed Jul 30, 2025D&A · Q3 2024: $55.0M · derived · 10-Q 0000813672-25-000148 filed Oct 29, 2025D&A · Q4 2024: $55.0M · derived · 10-K 0000813672-26-000016 filed Feb 19, 2026D&A · Q1 2025: $53.0M · 10-Q 0000813672-25-000051 filed Apr 30, 2025D&A · Q2 2025: $54.0M · derived · 10-Q 0000813672-25-000113 filed Jul 30, 2025D&A · Q3 2025: $57.0M · derived · 10-Q 0000813672-25-000148 filed Oct 29, 2025D&A · Q4 2025: $65.0M · derived · 10-K 0000813672-26-000016 filed Feb 19, 2026D&A · Q1 2026: $85.0M · 10-Q 0000813672-26-000047 filed May 1, 202684.647.6aQ2 2024Q1 2026Q2 2025
Q1 2026
84.6$M
All values (41)
PeriodValue ($M)Status
Q1 202684.6reported
Q4 202564.6derived
Q3 202556.7derived
Q2 202553.7derived
Q1 202552.9reported
Q4 202454.7derived
Q3 202455.0derived
Q2 202447.6derived
Q1 202439.6reported
Q4 202338.5derived
Q3 202336.4derived
Q2 202336.0derived
Q1 202334.4reported
Q4 202233.9derived
Q3 202230.5derived
Q2 202232.9derived
Q1 202234.8reported
Q4 202135.3derived
Q3 202135.2derived
Q2 202135.6derived
Q1 202136.2reported
Q4 202038.6derived
Q3 202037.1derived
Q2 202036.6derived
Q1 202033.3reported
Q4 201931.4derived
Q3 201930.2derived
Q2 201931.5derived
Q1 201929.7reported
Q4 201829.7derived
Q3 201829.7derived
Q2 201829.9derived
Q1 201829.4reported
Q4 201728.9derived
Q3 201728.3derived
Q2 201729.4derived
Q1 201728.9reported
Q4 201629.9derived
Q3 201627.0derived
Q2 201631.5derived
Q1 201631.2reported

CSV with all sources · Technical ID: dna

More metrics for Cadence

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$85.0M
Period
Q1 2026, ended Mar 31, 2026 · quarterly value (3 months, not cumulative)
Source
10-Q, filed May 1, 2026 · 0000813672-26-000047
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$85.0MMay 1, 202610-Q 0000813672-26-000047reported · confidence 1. · current